Mark A. Samuels

Mark Samuels is a proven entrepreneur, inventor and seasoned senior executive with a strong background in product development, commercialization and sales of medical devices. With over 20 years of experience in executive management and corporate governance for both public and privately held technology companies including women’s health, he brings a broad range of experience in government and strategic partner funding, equity investment, and IPO.

Mr. Samuels was previously CEO and co-founder of SpectRX, Inc., where he drove the valuation to almost $200 million as a NASDAQ company after a successful IPO. He established key strategic development partnerships with Abbott Laboratories, Roche Diagnostics, Respironics, Welch Allyn, and others. In 2018, Mr. Samuels completed the sale of OBMedical Company to Philips Medical, achieving a significant financial exit for OBMedical investors. Mr. Samuels assumed the role of turnaround CEO in 2016 and worked to recapitalize the company, correct the product problems, and grew product sales in 2017 and 2018 before the sale to Philips.

Mr. Samuels also led research, development and commercialization efforts covering four medical device products, including three now on the market and a non-invasive replacement for cervical cancer screening currently on the market outside the United States.

Mr. Samuels is a graduate of the Georgia Institute of Technology, where he earned a Bachelor of Science in Physics and a Master of Science. In addition, Mr. Samuels holds numerous patents, has earned an Emmy for technical innovation, and is a licensed pilot.